Precision Therapeutics, Forged by Evolution
Cutting-edge research aimed at improving treatment of GI diseases
Our Approach
Building Upon Nature
to Improve Gastrointestinal Health
Kissaki Biosciences is developing novel approaches
to treat gastrointestinal disorders, including:
- Inflammatory bowel disease (IBD)
- Infectious Diarrhea
Our innovative precision therapies are inspired by both natural and unnatural products, and seek to restore the ideal homeostasis.
Our Pipeline
Meet the Kissaki Team
Our team capitalizes on decades of drug development experience to
accelerate our treatments to and through the clinic.
About us
The Story & Purpose
Behind Our Name
Gorō Nyūdō Masamune was a medieval Japanese blacksmith
widely acclaimed as Japan’s greatest swordsmith.
In keeping with this tradition of excellence and innovation, we
chose the name Kissaki, which in Japanese, means the “tip of the
sword” or “cutting edge”. The hunt for cutting edge technologies
to treat human diseases is the core of our mission.
Innovation
Our Technology
We engineer disease targeting miniature proteins, leveraging AI modeling, and proven natural and unnatural scaffolds for potent, orally bioavailable therapeutics.
Inflammatory
Bowel Disease
Ulcerative Colitis (UC) and Crohn’s Disease (CD) are the major forms of Inflammatory Bowel Disease (IBD). Despite the large number of FDA and EMA-approved therapeutics, the unmet medical need remains high, and new therapeutics are needed.
Infectious Diarrhea
Infectious Diarrhea (ID) is a global health problem with lethal consequences for children in developing nations. Healthy adults are also affected as travelers to countries where ID is endemic, because they lack previous exposure and immunity to the causative agent.
Get in Touch With Us
Fill out this form to contact Kissaki Biosciences